Danny Rischin

A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours

Sunit Sarkar, Ben Tran, Lisa Horvath, Michael Lam, Peter Savas, Peter Grimison, James R Whittle, James C Kuo, Nicole Signal, David Edmonds, Philip Hogg, Danny Rischin, Jayesh Desai, Anne Hamilton

Journal article  |  2021  |  Cancer Chemotherapy and Pharmacology

PURPOSE: This phase I study was conducted to evaluate the safety and Maximum Tolerated Dose of PENAO (4-(N-(S-penicillaminylacetyl..

Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study

Richard J Young, Benjamin Solomon, June Corry, Christopher Angel, Lizbeth Kenny, Sandro Porceddu, Christopher Wratten, Andrew Macann, James E Jackson, Alan Herschtal, Danny Rischin

Journal article  |  2020  |  Oral Oncology

OBJECTIVE: Accurate determination of human papilloma virus (HPV) status is critical when identifying patients with oropharyngeal s..

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

Kevin J Harrington, Anthony Kong, Nicolas Mach, Jason A Chesney, Beatriz Castelo Fernandez, Danny Rischin, Ezra EW Cohen, Hoi-Shen Radcliffe, Burak Gumuscu, Jonathan Cheng, Wendy Snyder, Lillian L Siu

Journal article  |  2020  |  Clinical Cancer Research

PURPOSE: The prognosis for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) is poor, and on..

Prognostic gene expression signature for high-grade serous ovarian cancer

J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, MP Intermaggio, HS Leong, S Chen, W Elatre, B Gilks, T Nazeran, M Volchek, RC Bentley, C Wang, DS Chiu, S Kommoss, SCY Leung, J Senz, A Lum, V Chow, et al.

Journal article  |  2020  |  Annals of Oncology

BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies ..

Further clinical interpretation and implications of KEYNOTE-048 findings Reply

Barbara Burtness, Yayan Zhang, Kevin J Harrington, Danny Rischin

Journal article  |  2020  |  The Lancet

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies

Hisham Mehanna, Danny Rischin, Stuart J Wong, Vincent Gregoire, Robert Ferris, John Waldron, Quynh-Thu Le, Martin Forster, Maura Gillison, Sarbani Laskar, Makoto Tahara, Amanda Psyrri, Jan Vermorken, Sandro Porceddu

Journal article  |  2020  |  Journal of Clinical Oncology

Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is increasing rapidly. The younger age, significantly improved prog..

A Phase 3 randomized Double-blind Study of adjuvant Cemiplimab versus Placebo after Surgery and Radiotherapy for Patients with cutaneous squamous Cell Carcinoma Patients with high Risks

D Rischin, MG Fury, I Lowy, E Stankevich, S Li, H Han, SV Porceddu

Conference Proceedings  |  2020  |  JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

Sandro Porceddu, Christopher Daniels, Sue S Yom, Howard Liu, John Waldron, Vincent Gregoire, Alisha Moore, Michael Veness, Min Yao, Jorgen Johansen, Hisham Mehanna, Danny Rischin, Le Quynh-Thu

Journal article  |  2020  |  International Journal of Radiation: Oncology - Biology - Physics

Radiation therapy (RT) consensus contouring guidelines in the postoperative setting for complex cutaneous squamous cell carcinoma ..

Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy

Jason Toppi, Yik Seng Tham, Angela Webb, Michael A Henderson, Danny Rischin, Matthew JR Magarey

Journal article  |  2020  |  ANZ Journal of Surgery

BACKGROUND: Surgery is the primary treatment for patients with recurrent head and neck cutaneous squamous cell carcinoma (cSCC) wh..

Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus

Hisham Mehanna, John C Hardman, Jared A Shenson, Ahmad K Abou-Foul, Michael C Topf, Mohammad AlFalasi, Jason YK Chan, Pankaj Chaturvedi, Velda Ling Yu Chow, Andreas Dietz, Johannes J Fagan, Christian Godballe, Wojciech Golusinski, Akihiro Homma, Sefik Hosal, N Gopalakrishna Iyer, Cyrus Kerawala, Yoon Woo Koh, Anna Konney, Luiz P Kowalski, et al.

Journal article  |  2020  |  The Lancet Oncology

The speed and scale of the global COVID-19 pandemic has resulted in unprecedented pressures on health services worldwide, requirin..